Prostate Neoplasm — Trials

Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,542 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 548 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01946204	A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer(SPARTAN)	active not recruiting	Phase 3	1,207	Aragon Pharmaceuticals, Inc.INDUSTRY	25	Sep 28, 2026	clinicaltrials
NCT02257736	An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)	active not recruiting	Phase 3	982	Aragon Pharmaceuticals, Inc.